ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA(sic)-nonmutated advanced epithelial ovarian cancer
Author
Madry, R.
Fujiwara, K.
Vergote, I. B.
Sehouli, J.
Salutari, V.
Zola, P.
Wenham, R. M.
Korach, J.
Pautier, P.
Cibula, D.
Lheureux, S.
Hasegawa, K.
Kim, B-G.
Lai, C-H.
Gonzalez-Martinez, A.
Liu, Q.
Keefe, S. M.
Puglisi, M.
TOPUZ, Samet
Metadata
Show full item recordCollections
- Bildiri [64839]